Elon Musk, known for his unconventional antics and outspoken views, added a new layer of intrigue to his public persona this Christmas. The tech mogul, dressed as “Ozempic Santa” in a festive photo shared on his social media platform X, revealed his continued use of weight-loss medication.
In the accompanying post, Musk clarified that while he was initially using Ozempic, he has since switched to Mounjaro, another GLP-1 agonist. He explained that while Ozempic was effective, he experienced significant side effects, jokingly comparing them to “farting & burping like Barney from the Simpsons.”
“Ozempic Santa” Elon Musk Confesses He Switched To Mounjaro Because of Significant Side Effects: “Farting & Burping Like Barney From the Simpsons”
Musk’s admission comes as no surprise to those who have been following his fitness journey. The Tesla CEO has been a vocal proponent of weight-loss medications, particularly GLP-1 agonists, for some time. He has publicly argued for increased accessibility to these drugs, believing they could play a crucial role in combating obesity within the American population.
“Nothing would do more to improve the health, lifespan, and quality of life for Americans than making GLP inhibitors super low cost to the public,” he declared on X earlier this month.
Musk’s journey with weight-loss medication began in 2022 after a series of unflattering photos of him vacationing in Greece surfaced online. These images, which showed the billionaire lounging shirtless on a yacht, reportedly spurred him to prioritize his fitness.
“Frankly, I found those pics to be helpful motivation to lose weight!” he admitted on X last year.
The use of GLP-1 agonists for weight loss has become increasingly popular in recent years, particularly among celebrities and high-profile individuals. However, it’s important to note that these medications are primarily prescribed for the treatment of type 2 diabetes and may have potential side effects.
Musk’s public disclosure about his use of weight-loss medication is likely to reignite discussions about the accessibility and ethical implications of these drugs. As the debate surrounding weight loss and its societal impact continues, Musk’s candid admission adds another layer to this complex issue.
